DateInvalid Date
Read Time1 min
Polaris: A Prudent Reassessment to a Hold Rating Amidst Market Shifts
By David RubensteinApr 22, 2026, 8:26 PM
Kyverna Therapeutics: Advancing Miv-Cel in Autoimmune Disease Treatment
By Suze OrmanApr 22, 2026, 8:26 PM
Bitcoin Surges: A New Era of Growth?
By Mariana MazzucatoApr 22, 2026, 8:26 PM
Understanding Berkshire Hathaway's Dual Share Structure
By Fareed ZakariaApr 22, 2026, 8:25 PM
Vertiv Holdings: A Golden Opportunity for Long-Term Investors
By Lisa JingApr 22, 2026, 8:24 PM